<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Castells A</submitter><funding>Instituto de Salud Carlos III</funding><funding>Fundación Científica Asociación Española Contra el Cáncer</funding><pagination>e70169</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12920682</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Colorectal cancer (CRC) screening is effective and cost-effective in average-risk individuals. The COLONPREV study recently showed that individuals invited to a faecal immunochemical test (FIT) were more likely to participate in screening than those invited to colonoscopy, and that FIT-based screening was non-inferior to colonoscopy with respect to CRC-related mortality and CRC incidence.&lt;h4>Objective&lt;/h4>To assess whether the outcomes of colonoscopy- and FIT-based screening differ according to sex and age in the invited population.&lt;h4>Methods&lt;/h4>Presumptively healthy men and women aged 50-69 years were randomised to either a one-time screening colonoscopy or biennial FIT. In this analysis, we report participation and crossover rates, CRC-related mortality, CRC incidenc</pubmed_abstract><journal>United European gastroenterology journal</journal><pubmed_title>Sex- and Age-Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post-Analysis of the COLONPREV Study.</pubmed_title><pmcid>PMC12920682</pmcid><funding_grant_id>GCB13131592CAST</funding_grant_id><funding_grant_id>PI08/90717</funding_grant_id><funding_grant_id>AECC07185</funding_grant_id><pubmed_authors>Cubiella J</pubmed_authors><pubmed_authors>Morillas JD</pubmed_authors><pubmed_authors>Bujanda L</pubmed_authors><pubmed_authors>Coll-Vinent B</pubmed_authors><pubmed_authors>Castan-Cameo S</pubmed_authors><pubmed_authors>Andreu M</pubmed_authors><pubmed_authors>Diaz-Tasende J</pubmed_authors><pubmed_authors>Castells A</pubmed_authors><pubmed_authors>Serra-Burriel M</pubmed_authors><pubmed_authors>COLONPREV study investigators</pubmed_authors><pubmed_authors>Jover R</pubmed_authors><pubmed_authors>Lanas A</pubmed_authors><pubmed_authors>Carballo F</pubmed_authors><pubmed_authors>Frias-Arrocha E</pubmed_authors><pubmed_authors>Ono A</pubmed_authors><pubmed_authors>Quintero E</pubmed_authors><pubmed_authors>Hernandez C</pubmed_authors><pubmed_authors>Salas D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sex- and Age-Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post-Analysis of the COLONPREV Study.</name><description>&lt;h4>Background&lt;/h4>Colorectal cancer (CRC) screening is effective and cost-effective in average-risk individuals. The COLONPREV study recently showed that individuals invited to a faecal immunochemical test (FIT) were more likely to participate in screening than those invited to colonoscopy, and that FIT-based screening was non-inferior to colonoscopy with respect to CRC-related mortality and CRC incidence.&lt;h4>Objective&lt;/h4>To assess whether the outcomes of colonoscopy- and FIT-based screening differ according to sex and age in the invited population.&lt;h4>Methods&lt;/h4>Presumptively healthy men and women aged 50-69 years were randomised to either a one-time screening colonoscopy or biennial FIT. In this analysis, we report participation and crossover rates, CRC-related mortality, CRC incidenc</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Mar</publication><modification>2026-07-16T15:09:50.541Z</modification><creation>2026-07-09T11:03:31.557Z</creation></dates><accession>S-EPMC12920682</accession><cross_references><pubmed>41715250</pubmed><doi>10.1002/ueg2.70169</doi></cross_references></HashMap>